| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.093 | 0.5 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.078 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |